Histone deacetylase inhibition overcomes rapamycin resistance in diffuse large B-cell lymphoma by inhibiting Akt signaling via mTORC2 - Evidence review

In diffuse large B-cell lymphoma, cell and tumor studies show rapamycin can trigger AKT activation via mTORC2; HDAC inhibition may counter this response.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-19
DOI
https://doi.org/10.5281/zenodo.24366841
Primary Topic
Histone Deacetylase Inhibitors Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Histone deacetylase inhibition overcomes rapamycin resistance in diffuse large B-cell lymphoma by inhibiting Akt signaling via mTORC2 - Evidence review

Melania Mondini
Zenodo (CERN European Organization for Nuclear Research)
Histone Deacetylase Inhibitors Research
article

Histone deacetylase inhibition overcomes rapamycin resistance in diffuse large B-cell lymphoma by inhibiting Akt signaling via mTORC2 - Evidence review

Melania Mondini
article en

Abstract

In diffuse large B-cell lymphoma, cell and tumor studies show rapamycin can trigger AKT activation via mTORC2; HDAC inhibition may counter this response.

Zenodo (CERN European Organization for Nuclear Research)
Histone Deacetylase Inhibitors Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon